The Montreal Neurological Institute-Hospital, also known as Montreal Neuro or The Neuro, is a research and medical centre dedicated to neuroscience, training and clinical care, located in the city's downtown core of Montreal, Quebec, Canada.

There are 85 beds in Montreal Neurological Institute Clinical Research Unit.

During the past decade, Montreal Neurological Institute Clinical Research Unit conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Montreal Neurological Institute Clinical Research Unit" are "Alzheimer's Disease" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Aneurysmal Subarachnoid Hemorrhage" (1 trials), "Parkinson's Disease" (1 trials) and "Postherpetic Neuralgia" (1 trials). Many other conditions were trialed in "Montreal Neurological Institute Clinical Research Unit" in a lesser frequency.

Most popular intervention types in "Montreal Neurological Institute Clinical Research Unit" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Aducanumab" (1 trials), "BIIB054" (1 trials), "Bupivacaine HCl subcutaneous injection" (1 trials), "GTX-101" (1 trials) and "GTX-104" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montreal Neurological Institute Clinical Research Unit" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Montreal Neurological Institute Clinical Research Unit". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Montreal Neurological Institute Clinical Research Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Montreal Neurological Institute Clinical Research Unit, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".